SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-19-022636
Filing Date
2019-12-16
Accepted
2019-12-16 17:12:01
Documents
4
Group Members
ARGON MERGER SUB, INCMERCK SHARP & DOHME CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D nc10006926x1_sc13d.htm SC 13D 104241
2 EXHIBIT 99.2 nc10006926x1_ex99-2.htm EX-99.2 45194
3 EXHIBIT 99.3 nc10006926x1_ex99-3.htm EX-99.3 7556
4 nc10006926x1_ex99-2img01.jpg GRAPHIC 1726
  Complete submission text file 0001140361-19-022636.txt   161314
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803
Business Address ONE WALL STREET FLOOR 6 BURLINGTON MA 01803 781-994-0300
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48819 | Film No.: 191288018
SIC: 2834 Pharmaceutical Preparations